Jpmorgan Chase & CO Qiagen N.V. Transaction History

Jpmorgan Chase & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$35.55 - $43.57 $17.3 Million - $21.2 Million	487,364 Added 112.62%	920,102 $40 Million
Q3 2023 Nov 14, 2023	SELL	$39.13 - $47.24 $69.3 Million - $83.7 Million	-1,772,210 Reduced 80.37%	432,738 $17.5 Million
Q2 2023 Aug 11, 2023	BUY	$43.93 - $46.76 $30.6 Million - $32.6 Million	696,545 Added 46.18%	2,204,948 $99.3 Million
Q1 2023 May 11, 2023	BUY	$45.29 - $50.76 $10.8 Million - $12.1 Million	239,204 Added 18.85%	1,508,403 $69.3 Million
Q4 2022 Feb 13, 2023	BUY	$41.91 - $50.48 $20.7 Million - $24.9 Million	494,199 Added 63.77%	1,269,199 $63.3 Million
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $15.5 Million - $19 Million	377,763 Added 95.1%	775,000 $32 Million
Q2 2022 Aug 11, 2022	SELL	$42.98 - $49.77 $4.89 Million - $5.66 Million	-113,726 Reduced 22.26%	397,237 $18.8 Million
Q1 2022 May 11, 2022	BUY	$42.23 - $54.3 $4.23 Million - $5.44 Million	100,196 Added 24.39%	510,963 $25 Million
Q4 2021 Feb 10, 2022	SELL	$50.62 - $56.47 $28.1 Million - $31.3 Million	-554,621 Reduced 57.45%	410,767 $22.8 Million
Q3 2021 Nov 12, 2021	BUY	$46.55 - $56.83 $44.9 Million - $54.9 Million	965,388 New	965,388 $49.9 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.